Supplementary Table S2 from FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation
Authors:
- Ashley C. WoodsAshley C. Woods
- Kelly J. NorsworthyKelly J. Norsworthy
- Moran ChoeMCMoran Choe
- Brenda J. GehrkeBGBrenda J. Gehrke
- Haiyan ChenHCHaiyan Chen
- Jonathon VallejoJVJonathon Vallejo
- Lili PanLPLili Pan
- Xiling JiangXJXiling Jiang
- Hongshan LiHLHongshan Li
- Jeffrey KraftJKJeffrey Kraft
- Jiang LiuJiang Liu
- Rosane CharlabRCRosane Charlab
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)